Yesterday, we highlighted the first of our six AI-powered ProPicks strategies: Beat the S&P 500 - an actively managed equal-weighted portfolio that outperformed the US...
Explore Wall Street's expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with...
ProResearch offers comprehensive research analysis based on insights from top Wall Street analysts. These articles will soon be accessible exclusively to InvestingPro subscribers....
Amgen Inc (NASDAQ: AMGN) released new data from its Phase 2 study of dazodalibep for Sjögren's, a chronic (long-lasting) autoimmune disorder that happens when the immune system...
Investing.com — Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Amazon, Roku , Amgen, Chevron , Clorox, and TTM...
Amgen's (NASDAQ:AMGN) third-quarter 2023 financial results revealed a 4% increase in total revenues and a 6% rise in earnings per share compared to the previous year, according to...
Shares of Amgen (NASDAQ:AMGN) rose 3% in premarket trading Today after the biopharmaceutical company revised its 2023 revenue forecast upwards from $26.6B-$27.4B to a range of...